1-3 of 3
Matt L Cooper, PhD
Close
Sort by
Journal Articles

A Long-Acting Pharmacological Grade Interleukin-7 Molecule Logarithmically Accelerates Ucart Proliferation, Differentiation, and Tumor Killing

Matt L Cooper, PhD, Karl W. Staser, MD PhD, Julie Ritchey, Jessica Niswonger, Byung Ha Lee, PhD, Jaehan Park, John F. DiPersio, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2199.
https://doi.org/10.1182/blood-2018-99-117265
Published: 2018
Journal Articles

Chimeric Antigen Receptor T Cells Specific for CLL-1 for Treatment of Acute Myeloid Leukemia

Elisa De Togni, BA, Miriam Y Kim, MD, Matt L Cooper, PhD, Julie Ritchey, Julie O'Neal, PhD, Jessica Niswonger, John F. DiPersio, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2205.
https://doi.org/10.1182/blood-2018-99-113438
Published: 2018
Journal Articles

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Matt L Cooper, PhD, Jaebok Choi, PhD, Karl W. Staser, Julie Ritchey, Jessica Niswonger, Kayla Eckardt, Michael P Rettig, PhD, Wang Bing, Linda G Eissenberg, PhD, Armin Ghobadi, MD, Leah Gehrs, Julie Prior, PhD, Samuel Achilefu, Christopher A Miller, PhD, Catrina Fronick, Julie O'Neal, Feng Gao, PhD, David M. Weinstock, MD, Alejandro Gutierrez, MD, Robert S Fulton, John F DiPersio, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 844.
https://doi.org/10.1182/blood.V130.Suppl_1.844.844
Published: 2017